The One-Carbon Mistake That Cost A Patent Its Priority Date

Nobody likes the grammar police. Patent lawyers, unfortunately, may be the exception.

In Enanta Pharmaceuticals, Inc. v. Pfizer Inc. No. 2025-1427 (Fed. Cir. June 23, 2026), one character did a lot of damage. The difference between C2 and C1 cost Enanta the priority date of its provisional application—and led the Federal Circuit to affirm that the challenged claims were anticipated.

Turns out proofreading really can be worth millions.

But the case raises a more interesting question: Even if Enanta had … Read the rest

GeTtin’ SALTy Episode 80 | The Real Cost of Eliminating Property Taxes

In this episode of the GeTtin’ SALTy podcast, host Nikki E. Dobay is joined by Jared Walczak, Senior Fellow at the Tax Foundation and founder of Walczak Policy Consulting, to take a look at the growing movement to reduce or eliminate real property taxes across the United States.

The conversation centers on Jared’s recently published paper, “Replacing the Irreplaceable,” released through the Lincoln Institute of Land Policy, which uses Ohio as a case study to quantify what it would cost … Read the rest

As the cost of aging soars, families’ wealth is evaporating

Economists have talked about it as the greatest wealth transfer in history.

Baby boomers — boosted by decades of rising house prices, strong stock markets and economic growth — control more than half of U.S. household wealth. Estimates have predicted that $ 68 trillion to $ 84 trillion in money and assets will change hands over the next two decades.

But those estimates might not sufficiently account for the costs of growing old.

A Washington Post analysis of the finances of thousands of seniors … Read the rest

Supreme Court considers truck driver’s RICO case over CBD product that cost him his job  

Supreme Court considers truck driver’s RICO case over CBD product that cost him his job  

Share

The Supreme Court heard oral arguments on Tuesday in the case of a truck driver who was fired from his job after a wellness product marketed as free of THC, the active ingredient in marijuana,  caused him to fail a routine drug test. Douglas Horn sued the maker of the CBD product he took for chronic pain under federal racketeering law for economic harm.

But the companies that manufacture the product told the justices on Tuesday that because Horn’s … Read the rest